Recently, the carboxylesterase (CaE) activity/level in human plasma was reported to be a novel serological biomarker candidate for HCC, as proven in previously reported research results [27,28,29,30,31,32]. The gene discussed is GJA8; the disease is hepatocellular carcinoma.